EVALUASI NILAI GULA DARAH PADA PASIEN DIABETES MELLITUS TIPE II YANG MEMPEROLEH POLA TERAPI OAD TUNGGAL (Penelitian Dilakukan di Instalasi Rawat Inap RSU UMM)

Background: Type II diabetes mellitus is a metabolic disease characterized by
hyperglycemia. Currently, Indonesia ranks fifth with 19.5 million patients.
Management of type II diabetes mellitus requires a comprehensive approach, where
pharmacological therapy with oral antidiabetic drugs (OAD) becomes one of the
main pillars in achieving optimal glycemic control.
Research Objective: The objective of this study is to evaluate blood glucose
values (FBG, 2hPG, RBG) in Type II DM patients with single OAD therapy in the
inpatient unit of RSUMM.
Research Methods: This study uses a descriptive observational approach with
retrospective design and univariate analysis. Evaluation of patients' blood glucose
levels was conducted based on medical record data collected through time limit
sampling technique.
Results: Evaluation of type II DM inpatients at RSU UMM with OAD therapy
showed high glycemic target achievement: RBG 100% (2/2 patients <180 mg/dL),
FBG 75% (3/4 patients 80-130 mg/dL), and 2hPG 100% (3/3 patients <180 mg/dL)
according to PERKENI 2021 standards. Although blood glucose target achievement
reached 100%, this does not yet prove the effectiveness of OAD therapy.